News
Myosin Therapeutics awarded $4.5 million NCI Bridge Grant to advance phase I trial of MT-125 in glioblastoma: Jupiter, Florida Thursday, August 21, 2025, 18:00 Hrs [IST] Myosin Th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback